Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share news the company has announced the company is looking to complete a non-brokered private placement of up to 2.5 million dollars. Lightburn tells Proactive that placement includes a two key investments from Nammex and Negev. Lightburn also told Proactive the company looks to use the capital for drug discovery and development and intellectual property initiatives.
Filament Health adds to treasury with 2.5 million dollar private placement
